Skip to main content
impaact logo Return to homepage
  • Contact
    • Directory
  • About
    • Mission
    • Network Structure
      • Leadership
    • Areas of Research
      • HIV Complications and Co-Morbidities
      • HIV Cure
      • HIV Treatment
      • Tuberculosis
    • Funding Acknowledgements
    • Network Sites
    • Staff Spotlights
  • Studies
    • Research and Study Opportunities
    • Submit a Research Proposal
    • IMPAACT Study Snapshots
  • Community Engagement
    • ICAB Leadership Group
    • IMPAACT Community Advisory Board (ICAB)
    • Operations Center Staff
    • Resources
      • Acronyms
    • Site Community Advisory Boards
    • Community Meetings and Webinars
  • News & Events
    • Events and Conferences
    • IMPAACT Annual Meeting
    • Newsletters
    • Past Conference Presentations
  • Resources
    • COVID-19 Resources
    • HIV/AIDS Network Coordination (HANC)
    • Lab Center
      • Laboratory Committees
      • Laboratory Guidance Documents
      • Laboratory Resources for Quality Management
      • Specimen Repository
    • Manual of Procedures
    • Network Logos & Templates
    • Regulatory Resources
    • Training Opportunities
    • NIH Updates
  • Publications
    • Abstracts
    • Manuscripts
  • Enter a search term.

Breadcrumb

  1. Home
  2. Studies

Studies

Filter

Showing 117 studies.

P1007: Phase I Salvage Therapy

DAIDS Number

10315

Research Area

Other

Study Status

Concluded

P1006: Effects of HAART on Immune Function

DAIDS Number

10036

Research Area

Other

Study Status

Concluded

P1005: T-20 in HIV-1 Infected Children.

DAIDS Number

10314

Research Area

Other

Study Status

Concluded

P1004s: Intensive PK substudies in ACTG 403

DAIDS Number

10313

Research Area

Other

Study Status

Concluded

P1002s: Intensive PK substudy of saquinavir and nelfinavir

DAIDS Number

10312

Research Area

Other

Study Status

Concluded

ATN 052: Adolescent Population Genetics and Immune Response to Hepatitis B Vaccination

DAIDS Number

10368

Research Area

Other

Study Status

Concluded

ATN 023B: Barriers to HIV Medication

DAIDS Number

10475

Research Area

Other

Study Status

Concluded

Pagination

  • Previous page Prev
  • Page 1
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Current page 12
IMPAACT logo Return to homepage

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.

Stay connected with the IMPAACT Network

Follow IMPAACT

Sign up for our newsletter

Sitemap

© 2020 IMPAACT Network